Login / Signup
Terence Khoo
ORCID
Publication Activity (10 Years)
Years Active: 2020-2020
Publications (10 Years): 1
Top Topics
Tyrosine Kinase
Meta Analyses
Health Insurance
Advanced Non Small Cell Lung Cancer
Top Venues
Expert review of pharmacoeconomics & outcomes research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Terence Khoo
,
Lan Gao
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer in Australia.
Expert review of pharmacoeconomics & outcomes research
21 (3) (2020)